“…CEACAM16, previously described as carcinoembryonic antigen-related cell adhesion molecule 16, coding for a glycoprotein selectively expressed in the mammalian inner ear, secreted by cochlear outer hair cells of the organ of Corti, and localized to the tips of the tallest stereocilia and in the tectorial membrane (TM). In the TM, CEACAM16 interacts with other molecules such as glycoproteins α-tectorin (TECTA) and β-tectorin (TECTB), coded by TECTA and TECTB genes respectively, being a prominent component of TM's striated sheet structure relevant for hearing, resulting its targeted deletion in mice in patho-morphological TM defects and hearing loss [1][2][3][4]. Accordingly, CEACAM16 is a rare cause of NSHL in man, described in counted familial or in single cases, carriers of heterozygous or homozygous distinct sequence variants associated to dominant (ADNSHL; 1, 5-7) or recessive (ARNSHL) disease, also known as DFNA4B (Deafness, autosomal dominant 4B) and DFNB113 (Deafness, autosomal recessive 113) as referred in OMIM database (https://www.omim.org/entry/614591) [8][9][10].…”